Haleon PLC Logo

Haleon PLC

HLN | IL

Overview

Corporate Details

ISIN(s):
GB00BMX86B70 (+1 more)
LEI:
549300PSB3WWEODCUP19
Country:
United Kingdom
Address:
BUILDING 5, FIRST FLOOR, THE HEIGHTS, KT13 0NY WEYBRIDGE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Haleon PLC is a global leader in consumer healthcare, operating as a pure-play business dedicated to improving everyday health. Formerly the consumer healthcare division of GSK, the company's portfolio comprises a wide range of category-leading, over-the-counter (OTC) brands. Its core product areas include oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. Key brands under its management include Sensodyne, Panadol, Advil, Voltaren, and Centrum. With a global presence, Haleon focuses on delivering science-backed and trusted health products directly to consumers worldwide.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Haleon PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-21 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-20 14:20
Major Shareholding Notification
Holding(s) in Company
English 38.6 KB
2025-08-19 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.2 KB
2025-08-18 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-15 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-14 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-13 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-12 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-11 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-08 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-07 17:00
Major Shareholding Notification
Holding(s) in Company
English 38.5 KB
2025-08-07 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-06 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-05 10:15
Director's Dealing
Director/PDMR Shareholding
English 37.5 KB
2025-08-05 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB

Automate Your Workflow. Get a real-time feed of all Haleon PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Haleon PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
DEVA HOLDİNG A.Ş. Logo
Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.
Spain DEVA
Devyser Diagnostics Logo
Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.
Sweden DVYSR
Diamyd Medical AB (publ) Logo
Developing precision immunotherapies to preserve insulin in autoimmune diabetes.
Sweden DMYD
Diasorin Logo
Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.
Italy DIA
Dottikon ES Holding AG Logo
Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.
Switzerland DESN
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden DBP B
D.Western Therapeutics Institute, Inc. Logo Japan 4576
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom EAH
Eevia Health Plc Logo
B2B supplier of sustainable, scientifically validated extracts from Nordic plants for health brands.
Finland EEVIA
Egetis Therapeutics Logo
Develops and commercializes late-stage therapies for rare orphan diseases.
Sweden EGTX